参考文献/References:
[1] Porporato PE,Filigheddu N,Pedro JMB,et al.Mitochondrial metabolism and cancer[J].Cell Res,2018,28:265-280.
[2] Tan AS,Baty JW,Dong LF,et al.Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA[J].Cell Metab,2015,21:81-94.
[3] Yu M,Chen S,Hong W,et al.Prognostic role of glycolysis for cancer outcome:Evidence from 86 studies[J].J Cancer Res Clin Oncol,2019,145(4):967-999.
[4] Singh D,Arora R,Kaur P,et al.Overexpression of hypoxia-inducible factor and metabolic pathways:Possible targets of cancer[J].Cell Biosci,2017,7:62.
[5] Teoh ST,Lunt SY.Metabolism in cancer metastasis:Bioenergetics,biosynthesis,and beyond[J].Wiley Interdiscip Rev Syst Biol Med,2018,10(2):1406.
[6] Shiraishi T,Verdone JE,Huang J,et al.Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells[J].Oncotarget,2015,6(1):130-143.
[7] Vyas S,Zaganjor E,Haigis MC.Mitochondria and cancer[J].Cell,2016,166(3):555-566.
[8] Iommarini L,Ghelli A,Gasparre G,et al.Mitochondrial metabolism and energy sensing in tumor progression[J].Biochim Biophys Acta Bioenerg,2017,1858(8):582-590.
[9] Woo DK,Green PD,Santos JH,et al.Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+)mice[J].Am J Pathol,2012,180(1):24-31.
[10] Kumari S,Badana AK,Mohan GM,et al.Reactive oxygen species:A key constituent in cancer survival[J].Biomark Insights,2018,13:1177.
[11] Galadari S,Rahman A,Pallichankandy S,et al.Reactive oxygen species and cancer paradox:To promote or to suppress?[J].Free Radic Biol Med,2017,104:144-164.
[12] Jiang J,Wang K,Chen Y,et al.Redox regulation in tumor cell epithelial-mesenchymal transition:Molecular basis and therapeutic strategy[J].Signal Transduct Target Ther,2017,2:17036.
[13] Shimojo Y,Akimoto M,Hisanaga T,et al.Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells[J].Clin Exp Metastasis,2013,30(2):143-154.
[14] Mambo E,Chatterjee A,Xing M,et al.Tumor-specific changes in mtDNA content in human cancer[J].Int J Cancer,2005,116(6):920-924.
[15] Sun X,Zhan L,Chen Y,et al.Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer[J].Signal Transduct Target Ther,2018,3(1):8.
[16] Ishikawa K,Takenaga K,Akimoto M,et al.ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis[J].Science,2008,320(5876):661-664.
[17] Naito A,Cook CC,Mizumachi T,et al.Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA-depleted cells[J].Cancer Sci,2008,99(8):1584-1588.
[18] Luise MD,Girolimetti G,Okere B,et al.Molecular and metabolic features of oncocytomas:Seeking the blueprints of indolent cancers[J].Biochim Biophys Acta Bioenerg,2017,1858(8):591-601.
[19] Sabharwal SS,Schumacker PT.Mitochondrial ROS in cancer:Initiators,amplifiers or an Achilles' heel?[J].Nat Rev Cancer,2014,14:709-721.
[20] Guerra F,Perrone AM,Kurelac I,et al.Mitochondrial DNA mutation in serous ovarian cancer:Implications for mitochondria-coded genes in chemoresistance[J].J Clin Oncol,2012,30(36):e373-e378.
[21] Ericson NG,Kulawiec M,Vermulst M,et al.Decreased mitochondrial DNA mutagenesis in human colorectal cancer[J].PLoS Genet,2012,8(6):e1002689.
[22] Luo Y,Ma J,Lu W.The significance of mitochondrial dysfunction in cancer[J].Int J Mol Sci,2020,21(16):e5598.
[23] Zhao Y,Butler EB,Tan M.Targeting cellular metabolism to improve cancer therapeutics[J].Cell Death Dis,2013,4(3):e532.
[24] Liu Y,Cao Y,Zhang W,et al.A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis,induces cell-cycle arrest,and inhibits cancer cell growth in vitro and in vivo[J].Mol Cancer Ther,2012,11:1672-1682.
[25] Scafoglio CR,Villegas B,Abdelhady G,et al.Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma[J].Sci Transl Med,2018,10(467):5933.
[26] Simons AL,Ahmad IM,Mattson DM,et al.2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells[J].Cancer Res,2007,67(7):3364-3370.
[27] Evans JM,Donnelly LA,Emslie-Smith AM,et al.Metformin and reduced risk of cancer in diabetic patients[J].BMJ,2005,330(7503):1304-1305.
[28] Dowling RJ,Niraula S,Stambolic V,et al.Metformin in cancer:Translational challenges[J].J Mol Endocrinol,2012,48(3):31-43.
[29] Bridges HR,Jones AJY,Pollak MN,et al.Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria[J].Biochem J,2014,462:475-487.
[30] Wheaton WW,Weinberg SE,Hamanaka RB,et al.Metformin inhibits mitochondrial complex Ⅰ of cancer cells to reduce tumorigenesis[J].Elife,2014,3:e02242.
[31] Liu X,Romero IL,Litchfield LM,et al.Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers[J].Cell Metab,2016,24(5):728-739.
[32] Zhang DS,Li J,Wang FZ,et al.Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy[J].Cancer Lett,2014,355(2):176-183.
[33] Xue C,Wang C,Liu Q,et al.Targeting P-glycoprotein expression and cancer cell energy metabolism:combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin[J].Tumour Biol,2016,37:8587-8597.
[34] Millea PJ.N-acetylcysteine:Multiple clinical applications[J].Am Fam Physician,2009,80:265-269.
[35] Qin Y,Zhao D,Zhou HG,et al.Apigenin inhibits NF kappaB and snail signaling,EMT and metastasis in human hepatocellular carcinoma[J].Oncotarget,2016,7:41421-41431.
[36] 王 敏,李习平,杨 梅,等.Caspase信号途径及其在乳腺癌治疗中的作用研究进展[J].陕西医学杂志,2021,50(3):377-380.
[37] Day S,Gonzalez R,Lawson D,et al.Phase Ⅱ,randomized,controlled,double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage Ⅳ metastatic melanoma[J].J Clin Oncol,2009,27:5452-5458.
[38] Xiao D,Powolny AA,Moura MB,et al.Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells[J].J Biol Chem,2010,285:26558-26569.
[39] Chan DK,Miskimins WK.Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures[J].J Ovarian Res,2012,5:19.
[40] Yuzefovych LV,Kahn AG,Schuler MA,et al.Mitochondrial DNA repair through OGG1 activity attenuates breast cancer progression and metastasis[J].Cancer Res,2016,76(1):30-34.
[41] Akbari M,Keijzers G,Maynard S,et al.Overexpression of DNA ligase Ⅲ in mitochondria protects cells against oxidative stress and improves mitochondrial DNA base excision repair[J].DNA Repair,2014,16(1):44-53.
[42] 宋文沁,黄亚医,夏中元.线粒体自噬及其在肺脏疾病中的作用研究进展[J].陕西医学杂志,2018,47(10):1367-1369.
[43] Kim S,Nam HY,Lee J,et al.Mitochondrion-targeting peptides and peptidomimetics:Recent progress and design principles[J].Biochemistry,2020,59(3):270-284.
相似文献/References:
[1]李连香,于翠革,陈丽宏,等.miR-99b在新辅助化疗宫颈癌组织中的表达[J].陕西医学杂志,2016,(10):1292.
Li Lianxiang,Yu Cuige,Chen Lihong,et al.[J].,2016,(9):1292.
[2]安改丽,侯磊,李旭,等.miR-145对人乳腺癌MCF-7/ADR细胞耐药逆转的作用机制研究[J].陕西医学杂志,2017,(06):695.
[3]梁 天,朱晓明.趋化因子CCL28研究进展及其与肿瘤的关系*[J].陕西医学杂志,2019,(6):813.
[4]崔 佳,刘敏丽.乙酰左旋肉碱对脊髓损伤后线粒体的保护作用研究进展[J].陕西医学杂志,2021,50(3):374.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.031]
CUI Jia,LIU Minli.Protective effect of acetyl L-carnitine on mitochondria after spinal cord injury[J].,2021,50(9):374.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.031]
[5]张 星,高 明,赵 武,等.微小RNA-21对急性肾损伤模型大鼠线粒体氧化磷酸化的影响及机制研究[J].陕西医学杂志,2022,51(3):274.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.003]
ZHANG Xing,GAO Ming,ZHAO Wu,et al.Effect of microRNA-21 on oxidative phosphorylation of mitochondria in rats with acute renal injury and its mechanism[J].,2022,51(9):274.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.003]
[6]周 乐,徐佩尔,郑玉婷,等.紫杉醇促进心肌细胞微管结构稳定上调HO-1表达预防再灌注损伤的机制研究[J].陕西医学杂志,2022,51(11):1328.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.002]
ZHOU Le,XU Peier,ZHENG Yuting,et al.Mechanism of paclitaxel promoting microtubule structural stability in cardiac myocytes upregulating HO-1 expression to prevent reperfusion injury[J].,2022,51(9):1328.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.002]
[7]郭 勇,崔 森.红细胞凋亡在高原红细胞增多症中的作用研究进展[J].陕西医学杂志,2023,52(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.029]
[8]戴松松,刘 昉.甲状腺素信号通路调控自噬机制研究进展[J].陕西医学杂志,2023,52(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.028]
DAI Songsong,LIU Fang.Research progress on mechanism of thyroxine signaling pathway regulating autophagy[J].,2023,52(9):764.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.028]
[9]蔺 洁,雷 烨,李晓苗,等.小泛素化修饰调控糖尿病心肌病发生与发展[J].陕西医学杂志,2023,52(7):929.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.035]
LIN Jie,LEI Ye,LI Xiaomiao,et al.SUMO modification regulates occurrence and development of diabetic cardiomyopathy[J].,2023,52(9):929.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.035]
[10]张文娟,王琰琰,周静祎,等.微小RNA-181c-5p和Kruppel样因子6在子宫内膜样腺癌组织中的表达及其与患者临床病理特征关系研究[J].陕西医学杂志,2024,(4):552.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.026]
ZHANG Wenjuan,WANG Yanyan,ZHOU Jingyi,et al.Expression of miR-181c-5p and Kruppel-like transcription factor 6 and its relationship with clinicopathological features in endometrioid carcinoma tissues[J].,2024,(9):552.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.026]